These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 9500362)

  • 21. Clinical studies on efficacy and safety of acellular pertussis vaccine.
    Isomura S
    Tokai J Exp Clin Med; 1988; 13 Suppl():39-43. PubMed ID: 3078809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative immunogenicity and safety of different multivalent component pertussis vaccine formulations and a 5-component acellular pertussis vaccine in infants and toddlers: a randomized, controlled, open-label, multicenter study.
    Chatterjee A; O'Keefe C; Varman M; Klein NP; Luber S; Tomovici A; Noriega F
    Vaccine; 2012 May; 30(23):3360-8. PubMed ID: 22475857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and immunogenicity of Haemophilus influenzae-tetanus toxoid conjugate vaccine given separately or in combination with a three-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine for the first four doses.
    Halperin SA; King J; Law B; Mills E; Willems P
    Clin Infect Dis; 1999 May; 28(5):995-1001. PubMed ID: 10452624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pertussis and the pertussis vaccine.
    McKercher SW
    S D J Med; 1986 Jan; 39(1):5-11. PubMed ID: 3484836
    [No Abstract]   [Full Text] [Related]  

  • 25. ACIP issues statement on acellular pertussis vaccine.
    Am Fam Physician; 1992 Jul; 46(1):286, 291. PubMed ID: 1621635
    [No Abstract]   [Full Text] [Related]  

  • 26. [Pertussis vaccination: results of a KAP study of Apulia mothers].
    Germinario C; Quarto M; Lopalco PL; Sanguedolce A
    Ann Ig; 1993; 5(4):253-8. PubMed ID: 7524552
    [No Abstract]   [Full Text] [Related]  

  • 27. [Pertussis vaccination with acellular vaccines. Tolerance--effectiveness--current vaccination recommendations].
    Liese JG; Stojanov S; Belohradsky BH
    Fortschr Med; 1997 Aug; 115(24):22-7. PubMed ID: 9410815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants.
    Dashefsky B; Wald E; Guerra N; Byers C
    Pediatrics; 1990 Apr; 85(4 Pt 2):682-9. PubMed ID: 2107519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dose-response to a two-component acellular pertussis vaccine in infants and comparison with whole-cell vaccine.
    Auerbach BS; Lake AM; Wilson ME; Willingham FF; Shematek J; Moulton L; Deforest A; Halsey NA
    Biologicals; 1998 Jun; 26(2):145-53. PubMed ID: 9811522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The pertussis vaccine debate].
    Winter S
    Harefuah; 1982 Jun; 102(12):532-4. PubMed ID: 7160708
    [No Abstract]   [Full Text] [Related]  

  • 31. Pertussis vaccine.
    Singh J; Jindal A
    Indian Pediatr; 1989 Aug; 26(8):843-4. PubMed ID: 2620990
    [No Abstract]   [Full Text] [Related]  

  • 32. [85 per cent protection with vaccines against whooping cough. Three acellular multicomponent vaccines are best].
    Wilhelmson B
    Lakartidningen; 1995 Jul; 92(30-31):2830-2. PubMed ID: 7643694
    [No Abstract]   [Full Text] [Related]  

  • 33. Why do pertussis vaccines fail?
    Cherry JD
    Pediatrics; 2012 May; 129(5):968-70. PubMed ID: 22529282
    [No Abstract]   [Full Text] [Related]  

  • 34. Tetramune--a combined vaccine for infants.
    Med Lett Drugs Ther; 1993 Nov; 35(909):104-5. PubMed ID: 8232062
    [No Abstract]   [Full Text] [Related]  

  • 35. A randomized comparison of reactogenicity and immunogenicity of two whole-cell pertussis vaccines.
    Steinhoff MC; Reed GF; Decker MD; Edwards KM; Englund JA; Pichichero ME; Rennels MB; Anderson EL; Deloria MA; Meade BD
    Pediatrics; 1995 Sep; 96(3 Pt 2):567-70. PubMed ID: 7659477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.
    Grimprel E; von Sonnenburg F; Sänger R; Abitbol V; Wolter JM; Schuerman LM
    Vaccine; 2005 May; 23(28):3657-67. PubMed ID: 15882526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Detection of tolerance to diphtheria-pertussis-tetanus vaccines].
    Künzel W; Meissner C; Lüderitz U; Willkommen H; Winkler C
    Padiatr Grenzgeb; 1986; 25(2-3):197-203. PubMed ID: 3523392
    [No Abstract]   [Full Text] [Related]  

  • 38. [Three doses of pertussis vaccine should be recommended as a start].
    Taranger J; Trollfors B
    Lakartidningen; 1997 Dec; 94(49):4597-9. PubMed ID: 9445928
    [No Abstract]   [Full Text] [Related]  

  • 39. Pertussis vaccination.
    McAuliffe JS; Wadland WC
    Am Fam Physician; 1988 Mar; 37(3):231-5. PubMed ID: 3258115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tolerability of the Biken acellular pertussis vaccine in adults with or without previous vaccination against pertussis in childhood.
    Knuf M; Schmitt HJ; Mohnike K; Zepp F; Habermehl P; Kampmann C; Herden P
    Med Klin (Munich); 2004 Sep; 99(9):495-9. PubMed ID: 15372178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.